The fact that BRD4 inhibition could induce a small decrease in MDSCs within BRD4 myeloid–deficient mice with slightly smaller tumor volumes suggested the potential for the ability of inhibitors to exert a direct effect on tumor cells. Here, BRD4 is linked to neoplasm.